News and commentary from the world of neurology and neuroscience ...

A NEW screening for spinal muscular atrophy (SMA) is now being offered, included in the heel prick test, to all newborns in ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

We are thrilled that our Phase 2a study of intranasal foralumab in Multiple System Atrophy has been selected as a late-breaking poster at the 7th World Parkinson Congress,” said Ivor Elrifi, CEO of ...

Mayo Clinic's Translational Neuromuscular Disease Research Lab led by Nathan P. Staff, M.D., Ph.D., studies the biological ...

(SMA) causes progressive muscle weakness and, without treatment, can limit life expectancy to just two years. The milestone means the petition, to include SMA in post-birth baby checks for serious ...

ARVO and RWC abstracts feature analyses on biomarkers, mechanism of disease, patient experience and other data from IZERVAY ™ (avacincaptad pegol intravitreal solution) pivotal studies Astellas stands ...

Post hoc analyses of the AREDS/AREDS2 studies presented at the recent American Academy of Ophthalmology meeting examined supplementation on the risk of geographic atrophy progression. In this ...

To evaluate pancreatic atrophy in long-term transplant survivors, we retrospectively reviewed consecutive 42 patients with hematological malignancy after allogeneic PBSCT from related donors at our ...